IFNG and breast cancer: We now demonstrate that PGE2 inhibits IFN-γ induced CXCL9 and CXCL10 secretion from breast cancer cells and that, conversely, the COX inhibitors acetylsalicylic acid (ASA) and indomethacin augment this release.